Capital Group Private Client Services Inc. Purchases Shares

Capital Group Private Client Services Inc. purchased a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 6,354 shares of the biopharmaceutical company’s stock, valued at approximately $1,207,000. Other institutional […]

Related Keywords

South Korea , Korea , Sanfordc Bernstein , Raymond James , Stifel Nicolaus , Nasdaq , Fund Management Co , Alnylam Pharmaceuticals Inc , Geode Capital Management , Quarter For Alnylam Pharmaceuticals , News Ratings For Alnylam Pharmaceuticals Daily , Korea Investment , E Fund Management Co , Artal Group , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Company Profile , Capital Group Private Client Services Inc , Sei Investments Co , Alnylam Pharmaceuticals Trading Down , Capital Group Private Client Services , Free Report , Capital Management , Fund Management , Pharmaceuticals Trading Down , Get Free Report , Visit Holdingschannel , Alnylam Pharmaceuticals Daily , Nasdaq Alny , Dalny , Medical , 02043q10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,